Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion ; volume:13 ; number:1 ; day:11 ; month:7 ; year:2024 ; pages:1-6 ; date:12.2024
Experimental hematology & oncology ; 13, Heft 1 (11.7.2024), 1-6, 12.2024
- Creator
-
Klaihmon, Phatchanat
Samart, Parinya
Rojanasakul, Yon
Issaragrisil, Surapol
Luanpitpong, Sudjit
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-024-00534-2
- URN
-
urn:nbn:de:101:1-2409282100078.139612462150
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Klaihmon, Phatchanat
- Samart, Parinya
- Rojanasakul, Yon
- Issaragrisil, Surapol
- Luanpitpong, Sudjit
- SpringerLink (Online service)
Other Objects (12)
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
DFNA5 regulates immune cells infiltration and exhaustion
Chimeric Antigen Receptor T-Cell Therapy
Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
COVID-19: room for treating T cell exhaustion?
Next-generation immunotherapy to counteract T-cell exhaustion
IL-4 drives exhaustion of CD8+ CART cells
Engineering better chimeric antigen receptor T cells
The role of T-cell exhaustion for cancer immunotherapy
Exhaustion of CAR T cells: potential causes and solutions
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
DFNA5 regulates immune cells infiltration and exhaustion
Chimeric Antigen Receptor T-Cell Therapy
Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
COVID-19: room for treating T cell exhaustion?
Next-generation immunotherapy to counteract T-cell exhaustion
IL-4 drives exhaustion of CD8+ CART cells
Engineering better chimeric antigen receptor T cells
The role of T-cell exhaustion for cancer immunotherapy
Exhaustion of CAR T cells: potential causes and solutions
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
DFNA5 regulates immune cells infiltration and exhaustion
Chimeric Antigen Receptor T-Cell Therapy
Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
COVID-19: room for treating T cell exhaustion?
Next-generation immunotherapy to counteract T-cell exhaustion
IL-4 drives exhaustion of CD8+ CART cells
Engineering better chimeric antigen receptor T cells
The role of T-cell exhaustion for cancer immunotherapy